Q6
Brainy it is fact that it is a Phase 2/3 Trial. Ask the Question why we are conducting a third Phase 2 trial and does the Phase 2 refer to the US component of the trial, and if that is the case, why, what aren't the FDA happy with?
Q13
Dr Frazers words....from the newsletter.........
""While it had been proposed
to present interim safety data from CAN-003, the
ASCO review committee regrettably could not include
the presentation in the proceedings.""
So if the results are known why aren't they made available to shareholders/the market immediately????????
list of questions for the shholders briefing, page-9
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.005(1.27%) |
Mkt cap ! $588.3M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 41.0¢ | 38.5¢ | $952.5K | 2.391M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 140466 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 231265 | 14 |
View Market Depth
| Last trade - 13.17pm 03/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |